| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | IL32 Blocking Peptide for STJ501446 is synthetically produced from the 180-234 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | IL32 |
| Gene ID: | 9235 |
| Uniprot ID: | IL32_HUMAN |
| Immunogen Region: | 180-234 |
| Specificity: | This blocking peptide is recommended for use in combination with IL32 antibody, STJ501446 |
| Immunogen: | Synthetic pepetide taken within amino acid region 180-234 on human Interleukin-32 (natural killer cells protein 4). The synthetic peptide was post-synthetically modified and conjugated to KLH to achieve desired antigenicity. |
| Tissue Specificity | Selectively expressed in lymphocytes. Expression is more prominent in immune cells than in non-immune cells. |
| Function | Cytokine that may play a role in innate and adaptive immune responses. It induces various cytokines such as TNFA/TNF-alpha and IL8. It activates typical cytokine signal pathways of NF-kappa-B and p38 MAPK. |
| Peptide Name | Interleukin-32Il-32Natural Killer Cells Protein 4Tumor Necrosis Factor Alpha-Inducing Factor |
| Database Links | Reactome: R-HSA-449836Reactome: R-HSA-9013423 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Interleukin-32 proteinIl-32 proteinNatural Killer Cells Protein 4 proteinTumor Necrosis Factor Alpha-Inducing Factor proteinIL32 proteinNK4 proteinTAIF protein |
Information sourced from Uniprot.org
